Posts

Showing posts with the label R&D

Women’s Health – The Untapped Opportunity – Asrar Qureshi’s Blog Post #1062

Image
Women’s Health – The Untapped Opportunity – Asrar Qureshi’s Blog Post #1062 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1062 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Credit: Cnordic Nordic credit: MART Production Credit: Tima Miroshnichenko Credit: Yan Krukau This post is based on a McKinsey Report. Link at the end. Preamble Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately. Despite significant strides in medicine, women's health remains an underexplored and underfunded sector. Many health concerns that disproportionately affect women are not sufficiently researched or addressed. Conditions such as endometriosis, polycystic ovary syndrome (PCOS), and various reproductive cancers receive a fraction o...

Challenges for Pakistan Pharma Industry in 2023 – Part 1 – Asrar Qureshi’s Blog Post #771

Image
Challenges for Pakistan Pharma Industry in 2023 – Part 1 – Asrar Qureshi’s Blog Post #771 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #771 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Artem Podrez Photo Credit: Beatriz Fernandes Photo Credit: Polina Tankilevitch Pakistan Pharma Industry had a tough year in 2022, given the market situation, economy, and political turmoil. Economic conditions deteriorated further due to massive flooding in several parts of the country, particularly Sindh, which is still suffering due to wilful neglect, corruption, and embezzlement at all levels of management. Exchange rate fluctuations have been a constant factor affecting the cost of manufacturing. Despite such serious challenges,...

WIPO Global Innovation Index Report 2022 – Part 4 – Asrar Qureshi’s Blog Post #736

Image
WIPO Global Innovation Index Report 2022 – Part 4 – Asrar Qureshi’s Blog Post #736 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #736 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. These blog posts are based on WIPO – World Intellectual Property Rights Report on Global Innovation Index 2022. Photo Credit: Ali Madad Sakhirani Photo Credit: Assad Tanoli Photo Credit: RODNAE Production These two posts will be dedicated for Pakistan. Comparison with nearby countries shall follow later. PAKISTAN GII Rank #87 – Population 225 million – GDP, PPP 1,157 billion USD – GDP per capita 5,447 USD – Income level, Lower Middle. Out of 132 countries included in this report, Pakistan stood in the second quartile from the base. It means that Pakista...

Pakistan Pharma Industry SWOT – Part 32 – Asrar Qureshi’s Blog Post #623

Image
Pakistan Pharma Industry SWOT – Part 32 – Asrar Qureshi’s Blog Post #623 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #623 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Opening Note February 2022 marked my completing 47 years of working in Pharma Industry. Allah be praised. I am still working. My journey of near half century is also the journey of Pharma Industry in Pakistan. Great changes have occurred in this time and a lot could be written about it. In my blogs, which were started about four and a half years ago, I have covered several topics related to Pakistan Pharma Industry. This multi-part series shall do and review the SWOT – Strengths, Weaknesses, Opportunities, Threats – of the Pharma Industry. STRATEGIES It is now time to ...

Pakistan Pharma Industry SWOT – Part 13 – Asrar Qureshi’s Blog Post #604

Image
Pakistan Pharma Industry SWOT – Part 13 – Asrar Qureshi’s Blog Post #604 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #604 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Opening Note February 2022 marks my completing 47 years of working in Pharma Industry. Allah be praised. I am still working. The first half of my working career was spent in Multinational companies, and the latter half in the Local Pharma, making me well-versed with both innovators and generics markets. I also had the opportunity to work in business as well as operations.  My journey of near half century is also the journey of Pharma Industry in Pakistan. Great changes have occurred in this time and a lot could be written about it. In my blogs, which were started ...